These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38634345)

  • 21. Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices.
    Lu W; Stephens L; Shmookler A; O'Brien K; Karp JK; Hermelin D; Bakhtary S; Almozain N; George M; Fung M
    Transfusion; 2024 May; 64(5):839-845. PubMed ID: 38534065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
    Mair B; Benson K
    Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoprophylaxis for D- patients receiving platelet transfusions from D+ [correction of D-] donors?
    Menitove JE
    Transfusion; 2002 Feb; 42(2):136-8. PubMed ID: 11896325
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles?
    Kitazawa J; Nollet K; Morioka H; Tanaka K; Inomata M; Kubuki Y; Ohto H
    Vox Sang; 2011 May; 100(4):395-400. PubMed ID: 21029111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion.
    Zeiler T; Wittmann G; Zingsem J; Weisbach V; Zimmermann R; Eckstein R
    Vox Sang; 1994; 66(3):243. PubMed ID: 8036796
    [No Abstract]   [Full Text] [Related]  

  • 28. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness.
    Shao CP; Wang BY; Ye SH; Zhang WL; Xu H; Zhuang NB; Wu XY; Xu HG
    J Zhejiang Univ Sci B; 2012 Nov; 13(11):913-8. PubMed ID: 23125084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.
    Lozano M; Cid J
    Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients.
    McLeod BC; Piehl MR; Sassetti RJ
    Vox Sang; 1990; 59(3):185-9. PubMed ID: 2124754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-D Alloimmunization Following Rhesus-Incompatible Platelet Transfusion in a Myelodysplastic Syndrome Patient.
    Hanafi R; Zulkeflee RH; Hassan MN; Saidin NIS; Adzahar S; Hassan R
    Cureus; 2024 Mar; 16(3):e57165. PubMed ID: 38681415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
    Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF
    Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs.
    Boctor FN; Ali NM; Mohandas K; Uehlinger J
    Transfusion; 2003 Feb; 43(2):173-6. PubMed ID: 12559012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.
    Wang QP; Dong GT; Wang XD; Gu J; Li Z; Sun AY; Shao CP; Pan ZL; Huang LH; Xie WX; Sun GM; Chen JJ; Pei H; Yang XJ; Shan PN
    Blood Transfus; 2014 Apr; 12(2):238-43. PubMed ID: 23399369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.
    Zwiers C; Koelewijn JM; Vermij L; van Sambeeck J; Oepkes D; de Haas M; van der Schoot CE
    Transfusion; 2018 Jul; 58(7):1611-1617. PubMed ID: 29624682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.